首页> 美国卫生研究院文献>Chinese Medicine >Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats

【2h】

Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats

机译：退缩：一种新型中药组合可治疗大鼠中测试的晚期癌症和淋巴瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The author has withdrawn this article [] from the public domain because they did not have permission to use the data that was presented within. In the light of this situation, BioMed Central regrets that this article is no longer available. The author apologises to all parties for the inconvenience.

机译：作者之所以从公共领域撤回了本文[]，是因为他们无权使用其中提供的数据。鉴于这种情况，BioMed Central对本文不再可用感到遗憾。对于给您带来的不便，作者深表歉意。

著录项

期刊名称 Chinese Medicine
作者
Dawn N Waterhouse;
展开▼
作者单位

展开▼
年(卷),期 2010(5),-1
年度 2010
页码 10
总页数 1
原文格式 PDF
正文语种
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats [J] . Dawn N Waterhouse Chinese Medicine . 2010,第1期

机译：退缩：一种新型中药组合，可治疗大鼠中测试的晚期癌症和淋巴瘤
2. A novel combination of Chinese medicines to treat advanced cancers and lymphomas in rats [J] . Dawn N Waterhouse Chinese Medicine . 2009,第1期

机译：一种新型中药组合治疗大鼠晚期癌症和淋巴瘤
3. Innovative Strategy in Treating Angina Pectoris with Chinese Patent Medicines by Promoting Blood Circulation and Removing Blood Stasis: Experience from Combination Therapy in Chinese Medicine [J] . Xiong Xing-Jiang, Wang Zhong, Wang Jie Current vascular pharmacology . 2015,第4期

机译：活血化瘀中药治疗心绞痛的创新策略：中医药联合治疗的经验
4. One Case of Frequent Encapsulated Empyema Treated by the Combination of Traditional Chinese Medicine with Western Medicine [C] . The Third international congress on TCM : Collection of papers . 2001

机译：中西医结合治疗频发包膜脓胸1例。
5. Precision Medicine Approaches to Integrating Genomics with Cancer Therapy: Applications in Glioblastoma and Lymphoma [D] . Mooney, Marie R. 2016

机译：将基因组学与癌症治疗相结合的精密医学方法：在胶质母细胞瘤和淋巴瘤中的应用
6. Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab cyclophosphamide vincristine and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial [O] . Jeongkuk Seo, Won Seog Kim, Jin Seok Kim, 2017

机译：利妥昔单抗环磷酰胺长春新碱和泼尼松联合化疗（R-CVP）治疗的晚期边缘区淋巴瘤患者的血小板与淋巴细胞比率（PLR）保留独立的预后意义：改善淋巴瘤生存率的研究财团
7. Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats [O] . Dawn N Waterhouse 2010

机译：退缩：一种新型中药组合，可治疗大鼠中测试的晚期癌症和淋巴瘤

Retraction: a novel combination of Chinese medicines to treat advanced cancers and lymphomas tested in rats

摘要

著录项

相似文献

相关主题

期刊订阅